Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite
{{output}}
The (poly)pharmacology of drug metabolites is seldom comprehensively characterized in drug discovery. However, some drug metabolites can reach high plasma concentrations and display in vivo activity. Here, we use computational and experimental methods to compr... ...
